All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Next-Generation System for Federated Learning on Genomic Data

Public support

  • Provider

    Technology Agency of the Czech Republic

  • Programme

  • Call for proposals

    STA02025TQ180

  • Main participants

    DNAI s.r.o.

  • Contest type

    VS - Public tender

  • Contract ID

    TQ18000006 - Dodatek 1 ke smlouvě

Alternative language

  • Project name in Czech

    Next-Generation System for Federated Learning on Genomic Data

  • Annotation in Czech

    Cílem projektu je vytvoření studie proveditelnosti za účelem ověření technologické a ekonomické životaschopnosti průlomové inovace implementace unikátního federated learning frameworks v oblasti genomického výzkumu. Projekt je zaměřen na rozšíření stávajícího nástroje Floxgen o inovativní podporu federovaných výukových rámců, což mu umožní zpracovávat genetická data při zachování pravidel soukromí a v souladu s globálními předpisy pro sdílení dat. To bude zahrnovat přizpůsobení nástroje různým infrastrukturám (místní klastry, cloud atd.), jeho integraci s klíčovými modely federovaného učení a zvýšení jeho užitečnosti v oblasti genetického výzkumu.

Scientific branches

  • R&D category

    AP - Applied research

  • OECD FORD - main branch

    10201 - Computer sciences, information science, bioinformathics (hardware development to be 2.2, social aspect to be 5.8)

  • OECD FORD - secondary branch

    20206 - Computer hardware and architecture

  • OECD FORD - another secondary branch

    30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])

  • CEP - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    AF - Documentation, librarianship, work with information<br>BC - Theory and management systems<br>BD - Information theory<br>EI - Biotechnology and bionics<br>IN - Informatics<br>JC - Computer hardware and software

Completed project evaluation

  • Provider evaluation

    V - Vynikající výsledky projektu (s mezinárodním významem atd.)

  • Project results evaluation

    The technical side of the project is very well-developed, with a deep understanding of technological, market, economic and regulatory aspects. The extensive study uses appropriate methods (benchmark FL frameworks, proof-of-concept, market and investment analysis) and provides a realistic roadmap for implementation, including plans for QMS and compliance. The identified challenges include standardization of genomic data, higher resource requirements for production deployment and compliance with certification requirements, which must be taken into account in the next phase of the project. The project achieved all set goals and declared results, while bringing new and original outputs with high added value, which are suitable for immediate implementation. The solution significantly contributes to the fulfillment of the program objectives and has the potential for transnational application and significant social benefit at the national level.

Solution timeline

  • Realization period - beginning

    Apr 1, 2025

  • Realization period - end

    Sep 30, 2025

  • Project status

    U - Finished project

  • Latest support payment

    Feb 28, 2025

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP26-TA0-TQ-U

  • Data delivery date

    Jun 9, 2026

Finance

  • Total approved costs

    1,033 thou. CZK

  • Public financial support

    723 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    310 thou. CZK